10x Genomics to Report Fourth Quarter and Full Year 2024 Financial Results on February 12, 2025
10x Genomics (Nasdaq: TXG), a leader in single cell and spatial biology, has announced it will release its fourth quarter and full year 2024 financial results after market close on February 12, 2025. The company will hold a conference call and webcast for analysts and investors at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time on the same day.
The financial results will be available on the company's website before the conference call. Investors can access the live webcast through the 'Investors' section of 10x Genomics' website, where it will remain available for replay for at least 45 days following the event.
10x Genomics (Nasdaq: TXG), leader nella biologia cellulare singola e spaziale, ha annunciato che rilascerà i suoi risultati finanziari per il quarto trimestre e l'intero anno 2024 dopo la chiusura del mercato il 12 febbraio 2025. L'azienda terrà una conferenza telefonica e un webcast per analisti e investitori alle 13:30 ora del Pacifico / 16:30 ora dell'Est lo stesso giorno.
I risultati finanziari saranno disponibili sul sito web dell'azienda prima della conferenza telefonica. Gli investitori possono accedere al webcast dal vivo attraverso la sezione 'Investitori' del sito di 10x Genomics, dove rimarrà disponibile per la riproduzione per almeno 45 giorni dopo l'evento.
10x Genomics (Nasdaq: TXG), líder en biología de células individuales y espacial, ha anunciado que publicará sus resultados financieros del cuarto trimestre y del año completo 2024 después del cierre del mercado el 12 de febrero de 2025. La empresa llevará a cabo una llamada de conferencia y un webcast para analistas e inversores a la 1:30 p.m. hora del Pacífico / 4:30 p.m. hora del Este el mismo día.
Los resultados financieros estarán disponibles en el sitio web de la empresa antes de la llamada de conferencia. Los inversores pueden acceder al webcast en vivo a través de la sección 'Inversores' del sitio web de 10x Genomics, donde permanecerá disponible para reproducción durante al menos 45 días después del evento.
10x Genomics (Nasdaq: TXG)는 단일 세포 및 공간 생물학 분야의 선두주자로서, 2024년 4분기 및 전체 연도 재무 결과를 2025년 2월 12일 시장 종료 후 발표할 것이라고 발표했습니다. 회사는 같은 날 오후 1시 30분 태평양 표준시 / 오후 4시 30분 동부 표준시에 분석가 및 투자자를 위한 전화 회의 및 웹캣을 개최할 것입니다.
재무 결과는 회의 전 회사 웹사이트에서 제공될 예정입니다. 투자자들은 10x Genomics 웹사이트의 '투자자' 섹션을 통해 실시간 웹캣에 접근할 수 있으며, 이벤트 후 최소 45일 동안 다시 볼 수 있습니다.
10x Genomics (Nasdaq: TXG), un leader en biologie cellulaire unique et spatiale, a annoncé qu'il publiera ses résultats financiers du quatrième trimestre et de l'année complète 2024 après la fermeture du marché le 12 février 2025. L'entreprise tiendra une conférence téléphonique et un webcast pour les analystes et les investisseurs à 13h30, heure du Pacifique / 16h30, heure de l'Est, le même jour.
Les résultats financiers seront disponibles sur le site Web de la société avant la conférence téléphonique. Les investisseurs peuvent accéder au webcast en direct via la section 'Investisseurs' du site de 10x Genomics, où il restera disponible en replay pendant au moins 45 jours après l'événement.
10x Genomics (Nasdaq: TXG), ein führendes Unternehmen in der Einzelzell- und räumlichen Biologie, hat angekündigt, dass es seine Finanzergebnisse für das vierte Quartal und das gesamte Jahr 2024 nach Börsenschluss am 12. Februar 2025 veröffentlichen wird. Das Unternehmen wird am selben Tag um 13:30 Uhr pazifischer Zeit / 16:30 Uhr östlicher Zeit eine Telefonkonferenz und ein Webcast für Analysten und Investoren abhalten.
Die Finanzergebnisse werden vor der Telefonkonferenz auf der Website des Unternehmens verfügbar sein. Investoren können über den Bereich 'Investoren' auf der Website von 10x Genomics auf den Live-Webcast zugreifen, der mindestens 45 Tage nach der Veranstaltung zur Wiedergabe verfügbar bleibt.
- None.
- None.
Interested parties may access a live webcast of the fireside chat on the "Investors" section of the company's website at: https://investors.10xgenomics.com/. The webcast will be archived and available for replay for at least 45 days after the event.
About 10x Genomics
10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated solutions include instruments, consumables, and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems at a resolution and scale that matches the complexity of biology. Our products are behind breakthroughs in oncology, immunology, neuroscience, and more, fueling powerful discoveries that are transforming the world's understanding of health and disease. To learn more, visit 10xgenomics.com or connect with us on LinkedIn or X (Twitter).
Disclosure Information
10x Genomics uses filings with the Securities and Exchange Commission, our website (www.10xgenomics.com), press releases, public conference calls, public webcasts and our social media accounts as means of disclosing material non-public information and for complying with our disclosure obligations under Regulation FD.
Contacts
Investors: investors@10xgenomics.com
Media: media@10xgenomics.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/10x-genomics-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-12-2025-302362387.html
SOURCE 10x Genomics, Inc.
FAQ
When will 10x Genomics (TXG) release Q4 2024 earnings?
What time is the 10x Genomics (TXG) Q4 2024 earnings call?
How can I access the 10x Genomics (TXG) Q4 2024 earnings webcast?
How long will the 10x Genomics (TXG) Q4 2024 earnings webcast be available for replay?
